Volcano Cuts Deeper Into Peripheral Market With AtheroMed Buy
Volcano will pay $115 million, plus a potential milestone, for AtheroMed and its Phoenix atherectomy system, as part of the firm’s growing emphasis on the peripheral artery device market.
Volcano will pay $115 million, plus a potential milestone, for AtheroMed and its Phoenix atherectomy system, as part of the firm’s growing emphasis on the peripheral artery device market.